Literature DB >> 30755424

Hydrochlorothizide-induced acute generalised exanthematous pustulosis presenting with bilateral periorbital impetigo.

Leo E Reap1, Cassandra Rodd2, Jose Larios3, Michael Marshall3.   

Abstract

Acute generalised exanthematous pustulosis (AGEP) is a severe cutaneous adverse reaction characterised by the appearance of erythematous plaques and papules with overlying non-follicular pinpoint pustules. Drugs are the cause of AGEP in approximately 90% of cases. The most common causes include anti-infective agents (aminopenicillins, quinolones, antibacterial sulfonamides and terbinafine), antimalarials and diltiazem. To the best of our knowledge, to date there has only been one report of hydrochlorothiazide-induced AGEP. There has never been a case report of losartan-induced AGEP. Here, we present a case of AGEP that is the second case purportedly caused by hydrochlorothiazide. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cardiovascular system; dermatology; drug interactions unwanted effects / adverse reactions; drugs and medicines

Mesh:

Substances:

Year:  2019        PMID: 30755424      PMCID: PMC6381958          DOI: 10.1136/bcr-2017-223528

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

Review 1.  Acute generalized exanthematous pustulosis (AGEP)--a clinical reaction pattern.

Authors:  A Sidoroff; S Halevy; J N Bavinck; L Vaillant; J C Roujeau
Journal:  J Cutan Pathol       Date:  2001-03       Impact factor: 1.587

2.  Health care use and serious infection prevalence associated with penicillin "allergy" in hospitalized patients: A cohort study.

Authors:  Eric Macy; Richard Contreras
Journal:  J Allergy Clin Immunol       Date:  2013-11-01       Impact factor: 10.793

3.  Acute generalized exanthematous pustulosis caused by diltiazem.

Authors:  Hyun-Je Kim; Kyu-Dong Jung; Kyung-Tae Lee; Ji-Yeon Byun; Dong-Youn Lee; Joo-Heung Lee; Jun-Mo Yang; Eil-Soo Lee
Journal:  Ann Dermatol       Date:  2011-02-28       Impact factor: 1.444

Review 4.  Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.

Authors:  Rebecca Pavlos; Simon Mallal; David Ostrov; Yuri Pompeu; Elizabeth Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2014 Jan-Feb

5.  Cutaneous vasculitis overlap with acute generalised exanthematous pustulosis (AGEP).

Authors:  Aizuri Murad; Annette Murphy
Journal:  BMJ Case Rep       Date:  2014-11-17

Review 6.  Acute generalized exanthematous pustulosis (AGEP): A review and update.

Authors:  Jesse Szatkowski; Robert A Schwartz
Journal:  J Am Acad Dermatol       Date:  2015-09-06       Impact factor: 11.527

7.  Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinational case-control study (EuroSCAR).

Authors:  A Sidoroff; A Dunant; C Viboud; S Halevy; J N Bouwes Bavinck; L Naldi; M Mockenhaupt; J-P Fagot; J-C Roujeau
Journal:  Br J Dermatol       Date:  2007-09-13       Impact factor: 9.302

8.  Adverse reactions in the skin from anti-hypertensive drugs.

Authors:  K Thestrup-Pedersen
Journal:  Dan Med Bull       Date:  1987-12

Review 9.  Acute generalized exanthematous pustulosis: atypical presentations and outcomes.

Authors:  T C Kostopoulos; S M Krishna; N K Brinster; A G Ortega-Loayza
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-09-08       Impact factor: 6.166

Review 10.  Adverse cutaneous drug eruptions: current understanding.

Authors:  W Hoetzenecker; M Nägeli; E T Mehra; A N Jensen; I Saulite; P Schmid-Grendelmeier; E Guenova; A Cozzio; L E French
Journal:  Semin Immunopathol       Date:  2015-11-09       Impact factor: 11.759

  10 in total
  3 in total

1.  Multisystem organ failure secondary to acute generalised exanthematous pustulosis (AGEP) with atypical presentation resembling septic shock.

Authors:  Karen Cravero; Teja Chakrala; Andrew Shychuk
Journal:  BMJ Case Rep       Date:  2022-03-01

Review 2.  Drug Triggers and Clinic of Acute Generalized Exanthematous Pustulosis (AGEP): A Literature Case Series of 297 Patients.

Authors:  Enriqueta Vallejo-Yagüe; Adrian Martinez-De la Torre; Omar S Mohamad; Shweta Sabu; Andrea M Burden
Journal:  J Clin Med       Date:  2022-01-13       Impact factor: 4.241

Review 3.  Current Perspectives on Severe Drug Eruption.

Authors:  Jingzhan Zhang; Zixian Lei; Chen Xu; Juan Zhao; Xiaojing Kang
Journal:  Clin Rev Allergy Immunol       Date:  2021-07-17       Impact factor: 8.667

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.